胺碘酮和地高辛检测的陷阱及安全监测指南总结。
Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin.
作者信息
Smellie W Stuart A, Coleman Jamie J
机构信息
Clinical Laboratory, General Hospital, Bishop Auckland DL14 6AD.
出版信息
BMJ. 2007 Feb 10;334(7588):312-5. doi: 10.1136/bmj.39090.709537.47.
Abstract
Patients on a range of drug therapies are often not monitored appropriately, even though this can improve patient safety. Knowledge of the effects of drugs on non-target body systems is essential to guide monitoring and interpretation of monitoring tests
摘要
尽管适当监测可以提高患者安全性，但接受一系列药物治疗的患者往往没有得到适当监测。了解药物对非靶标身体系统的影响对于指导监测和解释监测测试至关重要。
相似文献
1
Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin.胺碘酮和地高辛检测的陷阱及安全监测指南总结。
BMJ. 2007 Feb 10;334(7588):312-5. doi: 10.1136/bmj.39090.709537.47.
2
Bidirectional ventricular tachycardia resulting from digoxin and amiodarone treatment of rapid atrial fibrillation.
Am J Emerg Med. 2004 May;22(3):235-6. doi: 10.1016/j.ajem.2004.02.034.
3
Dronedarone-induced digoxin toxicity: new drug, new interactions.地尔硫䓬导致的地高辛中毒：新药，新的相互作用。
Am J Ther. 2013 Nov-Dec;20(6):e717-9. doi: 10.1097/MJT.0b013e31821106c9.
4
A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.一项比较索他洛尔、胺碘酮和地高辛转复新发房颤的疗效和安全性的前瞻性随机对照试验。
Ann Emerg Med. 2000 Jul;36(1):1-9. doi: 10.1067/mem.2000.107655.
5
6
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation.地高辛-胺碘酮联合治疗与房颤患者全因死亡率增加相关。
Sci Rep. 2020 Mar 5;10(1):4101. doi: 10.1038/s41598-020-61065-4.
7
Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration.与血浆采样时间和胺碘酮给药相关的血浆地高辛浓度波动。
Pharmacotherapy. 2007 Mar;27(3):472-5. doi: 10.1592/phco.27.3.472.
8
Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial.索他洛尔或胺碘酮快速负荷给药用于近期发作的症状性心房颤动的治疗：一项随机、地高辛对照试验。
Am Heart J. 2004 Jan;147(1):E3. doi: 10.1016/s0002-8703(03)00526-x.
9
Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study.
Osteoporos Int. 2007 Apr;18(4):409-17. doi: 10.1007/s00198-006-0250-7. Epub 2006 Nov 9.
10
Amiodarone use is associated with increased risk of stroke in patients with nonvalvular atrial fibrillation: a nationwide population-based cohort study.胺碘酮的使用与非瓣膜性心房颤动患者中风风险增加相关：一项基于全国人群的队列研究。
Medicine (Baltimore). 2015 May;94(19):e849. doi: 10.1097/MD.0000000000000849.
引用本文的文献
1
[Antiarrhythmic drugs in the present day].[当今的抗心律失常药物]
Inn Med (Heidelb). 2024 Aug;65(8):762-769. doi: 10.1007/s00108-024-01745-9. Epub 2024 Jul 15.
2
Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications.前庭疾病中的药物-药物相互作用：临床问题及医学-法律影响。
Int J Environ Res Public Health. 2021 Dec 8;18(24):12936. doi: 10.3390/ijerph182412936.
3
Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital.根特大学医院药剂师干预的流行病学和成本分析。
Int J Clin Pharm. 2012 Oct;34(5):773-8. doi: 10.1007/s11096-012-9676-5. Epub 2012 Jul 19.
4
Ventricular arrhythmia in children: diagnosis and management.儿童室性心律失常：诊断与管理
Curr Treat Options Cardiovasc Med. 2008 Sep;10(5):442-7. doi: 10.1007/s11936-008-0036-7.
本文引用的文献
1
Best practice in primary care pathology: review 4.基层医疗病理学的最佳实践：综述4
J Clin Pathol. 2006 Sep;59(9):893-902. doi: 10.1136/jcp.2005.035212. Epub 2006 May 19.
2
Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice.监测胺碘酮的毒性：建议、证据与临床实践
Clin Pharmacol Ther. 2004 Jan;75(1):110-22. doi: 10.1016/j.clpt.2003.09.010.
3
Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy.胺碘酮与华法林相互作用的临床观察：长期治疗的剂量关系
Chest. 2002 Jan;121(1):19-23. doi: 10.1378/chest.121.1.19.
4
Lithium monitoring before and after the distribution of clinical practice guidelines.
Acta Psychiatr Scand. 2000 May;101(5):349-53. doi: 10.1034/j.1600-0447.2000.101005349.x.
5
Controversial aspects of thyroid disease.甲状腺疾病的争议性方面。
BMJ. 1999 Oct 2;319(7214):894-9. doi: 10.1136/bmj.319.7214.894.
6
Evaluating the appropriateness of digoxin level monitoring.评估地高辛血药浓度监测的适宜性。
Arch Intern Med. 1999 Feb 22;159(4):363-8. doi: 10.1001/archinte.159.4.363.
7
Techniques to improve physicians' use of diagnostic tests: a new conceptual framework.提高医生诊断检查使用水平的技术：一个新的概念框架。
JAMA. 1998 Dec 16;280(23):2020-7. doi: 10.1001/jama.280.23.2020.
8
Appropriateness of antiepileptic drug level monitoring.抗癫痫药物血药浓度监测的适宜性
JAMA. 1995;274(20):1622-6.
9
Hypomagnesaemia in elderly digitalised patients.老年洋地黄化患者的低镁血症
Scott Med J. 1988 Jun;33(3):273-4. doi: 10.1177/003693308803300309.
10
Therapeutic drug monitoring reduces toxic drug reactions: a meta-analysis.
Ther Drug Monit. 1990 Jan;12(1):72-8. doi: 10.1097/00007691-199001000-00013.
Zotero 插件